Top Tweets for #fredsaad
First line Metastatic Castration-Resistant Prostate Cancer (mCRPC) from #FredSaad: https://t.co/KzWEOTgjuX
Hi friends, it's #ProstateCancer Friday! #ASCO26 edition 🎉🎉🎉
Here are Top Posts of the Week 🧵
1/ @neerajaiims on Ab#5020 by #FredSaad on subgroup analyses in PSMAddition:
https://t.co/DGvO494Qbp
Ab#5020 @ASCO #ASCO26 by #FredSaad👉 https://t.co/3GzUW8ftvE👉subgroup analyses in PSMAddition #prostatecancer👉Lu-177+ADT+ARPI⬆️rPFS vs ADT+ARPI across high/low vol & de novo/recurrent PSMA+ mHSPC👇@OncoAlert @urotoday @PCF_science @DrScottTagawa @mishabeltran @OpenMedicineHQ
Ab#5020 @ASCO #ASCO26 by #FredSaad👉 https://t.co/3GzUW8ftvE👉subgroup analyses in PSMAddition #prostatecancer👉Lu-177+ADT+ARPI⬆️rPFS vs ADT+ARPI across high/low vol & de novo/recurrent PSMA+ mHSPC👇@OncoAlert @urotoday @PCF_science @DrScottTagawa @mishabeltran @OpenMedicineHQ
🗣️Prostate Rapid Oral Abstracts #GU26
👉Dr #FredSaad presenting phase 1 #PAnTHa investigating #225AcPSMA in pts w/ mCRPC.
N = 50 mCRPC s/p ARPI, 1-2 taxanes (58%, 20%)
⚠️TRAEs
Dry Mouth = 76% (G1 52%, G2 24%, >G3 0%)
Fatigue = 48%
Nausea = 44%
⚠️>G3 TRAE = 38%
Lymphopenia = 20%
ALL RDE
🩸 PSA 50 = 58% 83%
🩸 PSA 90 = 36% 58%
🔑Key Data underscoring efficacy of #225AcPSMA in pts with SUV mean >10. Pts selection and Dose optimization necessary to minimized dry mouth and TRAEs.
@neerajaiims @bergsa83 @PBarataMD @Dr_RaviMadan @OncBrothers @OncoAlert @urotoday @Uromigos @DrChoueiri @yekeduz_emre @HJacene @PrafulRavi1
Ab#19 @ASCO #GU26 by #FredSaad👉https://t.co/uDqCr5G5F1👉Ph1 trial of 225Ac-PSMA-Trillium in mCRPC #prostatecancer👉No DLTs👉promising PSA50 83% at 125 kBq/kg (RDE), ORR 46%,⬆️response in PSMA PET SUVmean>10👇 #JohannDeBono @OncoAlert @urotoday @PCF_Science @sebastienhotte
Congrats Alicia @CaPsurvivorship for oral ab#5004 @ASCO #ASCO25 👉https://t.co/rsGcdqfN31👉HRQoL data from ph3 ARANOTE trial #prostatecancer 👉Darolutamide improved overall well-being, pain & symptoms vs placebo 👇 #FredSaad @OncoAlert @urotoday @PCF_Science
At #UromigosLive24 👉ADT+Darolutamide vs. ADT in ph3 ARANOTE in pts w/ mHSPC #ProstateCancer from #ESMO24 👉Adding darolutamide significantly prolonged rPFS (HR 0.54) w/ a favorable safety profile 👉https://t.co/0XEs6Lnpsg👇
#FredSaad @PCF_Science @Uromigos @urotoday @OncoAlert
Terrific thesis on molecular biology by @CharlesDariane Congratulations and very proud to have a new phD in my urology team @UrologieParis @FAudenet @APHP @HopitalPompidou @univ_paris_cite Thank U to the jury with #fredsaad @MRoupret @GOFFINVincent2
A Real MTD team to discuss about #ProstateCancer. A lot to learn from #FredSaad @LauBernalOnc @raymanneh @LuisSalgadoS & questions from @zapatalaguadomd that should have joined the pic!!!! #Enlazate 🇨🇴
How to manage treatments in metastatic urothelial and prostate cancers ?
☀️☀️☀️☀️☀️
Amazing panel and key messages given by the dream team. @RoubaudG @evanguelosx @tompowles1 #fredsaad #gwenaellegravis
@FOCUS_meeting #focus2022 #Focus #focus22
So glad to hear and meet again in person in Paris at #ESMO22 congress one of my mentor #FredSaad @chumontreal 1 year after completing my fellowship in #Montreal @CRCHUM on #ProstateCancer
The awaited #PROpel biomarker analysis by esteemed #FredSaad — rPFS of abi-olaparib best for patients w BRCA1/2 alterations, next for those w homologous recombination repair defects, finally in non-HRR altered. OS benefit holds in intention to treat group. #ESMO22 @OncoAlert
Thank @cancermtl for such a interesting day. @CRCHUM @MaximeCahuzac @LBrureau #FredSaad #prostatecancer
🎉🎉THE event will be in #Toulouse.
🏅 Focus meets BELGIUM
🤝🤝Spécial Guests : @DrMHofman
@piet_ost
@tompowles1
#FredSaad @PietDirix @Achard_Verane
@fontev1 @AlbigesL
@MRoupret @VickersBiostats
@NoraSundahl @ThRoumeguere
And... Surprise 🎁🎁🎀🎀
https://t.co/arFiQ9a6pn
A great overview from #FredSaad on #PROPEL trial — olaparib with abiraterone improved rPFS in HRR unselected #prostatecancer populations. We enrolled to this study @DukeGUCancer — @Daniel_J_George @AarmstrongDuke
3/ ACIS Phase 3 trial: Combo apalutamide + abiraterone (vs. abiraterone/placebo) in patients with mCRPC => improved rPFS & an acceptable safety profile @DRathkopf @EfstathiouEleni @AttardLab @PCFnews #FredSaad @chumontreal @TheLancetOncol
https://t.co/hANSqExaA5
Wonderful to work with great steering committee led superbly by @neerajaiims and #FredSaad on this important @pfizer trial testing upfront #PARPi in metastatic castration-sensitive #ProstateCancer with DDR alterations. @quimmateo #precisionmedicine
Looking forward to working with the @pfizer team on this new global phase 3 registration trial in men with new metastatic castration sensitive #prostatecancer with HRRm @quimmateo @AzadOncology @FredSaad Weblink👉 https://t.co/f35j7yThIo Design👇@OncoAlert
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers